BioSpace News Archive

SenesTech, Inc. announced Joel Fruendt, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking place virtually on May 18, 2023.

Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today reported financial results for the first quarter of 2023 following the recently completed, successful PF614-MPAR-101 study.

Vaccinex, Inc. (Nasdaq: VCNX) today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key programs and financing in the first five months of the year.

PHC Corporation of North America, supplier of the PHCbi brand of cell preservation and growth products in the North America and Latin America markets, is pleased to announce that the PHCbi brand VIP ECO® SMART ultra-low temperature freezer has been awarded the prestigious Outstanding New Product Award for 2023 by the International Society for Biological and Environmental Repositories.

Koning Corporation, the leading manufacturer of breast computed tomography systems, announced that it has received the largest pipeline of orders in its history.

Biologist and famed atheist Richard Dawkins has repeatedly described a test that he predicted would prove evolution, but now, mounting scientific evidence shows that the same test instead proves intelligent design, says Discovery Institute’s Center for Science & Culture.

Reviva Pharmaceuticals Holdings, Inc. today reported financial results for the first quarter ended March 31, 2023 and summarized recent business highlights.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, provided a corporate update and reported financial results for the first quarter ended March 31, 2023.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three months ended March 31, 2023.

Exagen Inc., a leading provider of autoimmune testing solutions, reported financial results for the quarter ended March 31, 2023.